Ownership

Kevin Koch - President and CEO, Director at Edgewise Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: President and CEO, Director
Stock Symbol: EWTX on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Kevin Koch - trading volume in the past year for Edgewise Therapeutics, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-3.15K	100%	$18.91	-$59.6K
Net	-3.15K	-100%		-$59.6K

Holdings reported by Kevin Koch for Edgewise Therapeutics, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Restricted Stock Units	71.9K	$1.36M	$18.91	Aug 12, 2024	Direct	Common Stock
Common Stock	26.4K	$499K	$18.91	May 1, 2024	Indirect
Common Stock	14.5K	$274K	$18.91	May 2, 2024	Direct
Stock Option (Right to Buy)	431K			Aug 12, 2024	Direct	Common Stock

Transactions reported by Kevin Koch for Edgewise Therapeutics, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.